icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
 
 
 
C-EDGE CO-STAR: Favorable Impact of Elbasvir and Grazoprevir on Health-Related Quality of Life in Treatment-Na´ve HCV-Infected Persons Who Inject Drugs Receiving Opioid Agonist Therapy
 
 
  Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
 
Jean Marie Arduino*1, Oren Shibolet2, Alain H. Litwin3, Jason Grebeley4, Frederick Altice5, Chizoba Nwankwo1, T. Christopher Mast1, Zhiwei Jiang1, Isaias N. Gendrano1, Heather L. Platt1, Gregory J. Dore4
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Tel-Aviv Medical Center and Tel-Aviv University, Tel-Aviv, Israel; 3Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA; 4The Kirby Institute, UNSW, Sydney, Australia; 5Yale School of Medicine, New Haven, CT, USA

EASL1

EASL2

EASL3

EASL4

EASL5

EASL6

EASL7